Parametric Portfolio Associates LLC Reduces Stake in Hill-Rom Holdings Inc (HRC)

Parametric Portfolio Associates LLC trimmed its position in Hill-Rom Holdings Inc (NYSE:HRC) by 7.5% in the second quarter, according to its most recent filing with the SEC. The fund owned 168,587 shares of the medical technology company’s stock after selling 13,742 shares during the period. Parametric Portfolio Associates LLC owned 0.26% of Hill-Rom Holdings worth $13,421,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Canada Pension Plan Investment Board lifted its stake in shares of Hill-Rom Holdings by 42.7% in the 2nd quarter. Canada Pension Plan Investment Board now owns 16,700 shares of the medical technology company’s stock valued at $1,329,000 after acquiring an additional 5,000 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of Hill-Rom Holdings by 1,191.1% in the 2nd quarter. American Century Companies Inc. now owns 110,359 shares of the medical technology company’s stock valued at $8,786,000 after acquiring an additional 101,811 shares during the last quarter. Prudential Financial Inc. lifted its stake in shares of Hill-Rom Holdings by 6.6% in the 2nd quarter. Prudential Financial Inc. now owns 545,786 shares of the medical technology company’s stock valued at $43,449,000 after acquiring an additional 33,714 shares during the last quarter. Brookstone Capital Management bought a new position in shares of Hill-Rom Holdings in the 2nd quarter valued at $289,000. Finally, Chase Investment Counsel Corp bought a new position in shares of Hill-Rom Holdings in the 2nd quarter valued at $675,000. Institutional investors own 82.31% of the company’s stock.

In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 6,870 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the completion of the sale, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at $1,293,993.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the completion of the sale, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Parametric Portfolio Associates LLC Reduces Stake in Hill-Rom Holdings Inc (HRC)” was reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://ledgergazette.com/2017/10/10/parametric-portfolio-associates-llc-reduces-stake-in-hill-rom-holdings-inc-hrc.html.

Hill-Rom Holdings Inc (HRC) opened at 75.92 on Tuesday. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The company has a market capitalization of $5.00 billion, a PE ratio of 44.24 and a beta of 1.19. The stock has a 50 day moving average price of $75.40 and a 200-day moving average price of $76.04.

Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. The company had revenue of $689.10 million during the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.81 earnings per share. On average, equities analysts predict that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, September 29th. Shareholders of record on Friday, September 15th were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.95%. The ex-dividend date of this dividend was Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is presently 41.62%.

A number of research analysts have recently commented on HRC shares. Cantor Fitzgerald started coverage on Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “neutral” rating and a $86.00 price target for the company. Needham & Company LLC started coverage on Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “buy” rating and a $95.00 price target for the company. Morgan Stanley increased their price target on Hill-Rom Holdings from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, June 30th. Zacks Investment Research cut Hill-Rom Holdings from a “buy” rating to a

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Canada Pension Plan Investment Board lifted its stake in shares of Hill-Rom Holdings by 42.7% in the 2nd quarter. Canada Pension Plan Investment Board now owns 16,700 shares of the medical technology company’s stock valued at $1,329,000 after acquiring an additional 5,000 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of Hill-Rom Holdings by 1,191.1% in the 2nd quarter. American Century Companies Inc. now owns 110,359 shares of the medical technology company’s stock valued at $8,786,000 after acquiring an additional 101,811 shares during the last quarter. Prudential Financial Inc. lifted its stake in shares of Hill-Rom Holdings by 6.6% in the 2nd quarter. Prudential Financial Inc. now owns 545,786 shares of the medical technology company’s stock valued at $43,449,000 after acquiring an additional 33,714 shares during the last quarter. Brookstone Capital Management bought a new position in shares of Hill-Rom Holdings in the 2nd quarter valued at $289,000. Finally, Chase Investment Counsel Corp bought a new position in shares of Hill-Rom Holdings in the 2nd quarter valued at $675,000. Institutional investors own 82.31% of the company’s stock.

In other Hill-Rom Holdings news, SVP Andreas G. Frank sold 6,870 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the completion of the sale, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at $1,293,993.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the completion of the sale, the senior vice president now directly owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Parametric Portfolio Associates LLC Reduces Stake in Hill-Rom Holdings Inc (HRC)” was reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://ledgergazette.com/2017/10/10/parametric-portfolio-associates-llc-reduces-stake-in-hill-rom-holdings-inc-hrc.html.

Hill-Rom Holdings Inc (HRC) opened at 75.92 on Tuesday. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The company has a market capitalization of $5.00 billion, a PE ratio of 44.24 and a beta of 1.19. The stock has a 50 day moving average price of $75.40 and a 200-day moving average price of $76.04.

Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. The company had revenue of $689.10 million during the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.81 earnings per share. On average, equities analysts predict that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, September 29th. Shareholders of record on Friday, September 15th were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.95%. The ex-dividend date of this dividend was Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is presently 41.62%.

A number of research analysts have recently commented on HRC shares. Cantor Fitzgerald started coverage on Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “neutral” rating and a $86.00 price target for the company. Needham & Company LLC started coverage on Hill-Rom Holdings in a research note on Thursday, June 29th. They issued a “buy” rating and a $95.00 price target for the company. Morgan Stanley increased their price target on Hill-Rom Holdings from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Friday, June 30th. Zacks Investment Research cut Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Tuesday, July 11th. Finally, BidaskClub cut Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $87.80.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply